Primary Care Colloquium — Synergy in the Treatment of Heart Failure

This program happened in the past, and no dates are currently scheduled.

Select this button to navigate the sections of this page

Conference ID

J6015-17

Agenda

  • 8 a.m. | Check In / Continental Breakfast
  • 8:30 a.m. | Advanced Heart Failure: Patient Identification and Treatment Options
    Omaima Ali, MD
    Identify the epidemiology, pathophysiology, and treatment options associated with heart failure as well as the classification of disease severity and progression
  • 9 a.m. | Heart Failure: Transitional Care
    Sara Black, MSN, CRNP, NP-C
    Discuss methods of optimizing the medical management of heart failure as well as strategies to avoid rehospitalization of those living with the disease
  • 9:30 a.m. | Remote Physiology Monitoring for Heart Failure Patients
    John Boehmer, MD
    Explain the methods of optimizing outpatient heart failure management as well as strategies to avoid hospitalization of those living with the disease
  • 10 a.m. | Heart Failure with Preserved Ejection Fraction: A Major Cause of Pulmonary Hypertension?
    David H. Silber, MD
    Review the definition and World Health Organization classification of pulmonary hypertension, and discuss the current treatment options for heart failure associated with pulmonary hypertension
  • 10:30 a.m. | Break / Networking / Exhibits
  • 10:45 a.m. | Surgical Treatment for Advanced Heart Failure
    Behzad Soleimani, MD
    Discuss the course of action and treatment options for patients living with end-stage heart failure
  • 11:15 a.m. | Palliative Care and When and How to Have Difficult Conversations
    Lisa Kitko, RN, PhD, FAHA
    Describe the stages of heart failure, communication about prognosis, and the advanced care planning appropriate for each stage
  • 11:45 a.m. | Heart Failure Pharmacology: What is New?
    Michelle Haydo, PharmD
    Review the recently revised medication recommendations from the American College of Cardiology (ACC)/American Heart Association (AHA), and the literature supporting these recommendations
  • 12:15 p.m. | Networking Lunch / Wrap-up / Program Evaluation

Faculty

Penn State College of Medicine | Penn State Milton S. Hershey Medical Center | Penn State Heart and Vascular Institute

Omaima Ali, MD
Assistant Professor of Medicine
Department of Cardiology

Sara Black, MSN, CRNP, NP-C
Family Nurse Practitioner
Department of Cardiology

John Boehmer, MD
Professor of Medicine
Department of Cardiology

Michelle Haydo, PharmD, BCACP
Clinical Pharmacist
Heart Failure Transitional Care

Lisa Kitko, RN, PhD, FAHA
Assistant Professor
Penn State College of Nursing
University Park, PA

David H. Silber, MD
Associate Professor of Medicine
Department of Cardiology

Behzad Soleimani, MD
Assistant Professor of Surgery
Cardiothoracic Surgery

Fee

There is no fee for this program, but registration is required.

Credit

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses using AMA Credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in 3.5 hours of approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing.

Accreditation Council for Pharmacy Education (ACPE)

Penn State Health Milton S. Hershey Medical Center is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned the Universal Activity Number of 0322-0000-17-002-L01-P. It has been approved for 3.5 Contact hours or 0.35 CEUs of continuing pharmacy education credit in states that recognize ACPE providers. The attendee list will be uploaded into CPE Monitor approximately one week after completion of the program. Statements of credit indicated in contact hours and CEUs will be available through CPE Monitor. Successful completion includes signing in at registration with personal NABP number and date of birth, attending the entire session for which credit is claimed, and completing the activity evaluation. Penn State Health Milton S. Hershey Medical Center complies with the Accreditation Standards for Continuing Education.

Audience

General, internal, and family medicine physicians, physician assistants, nurse practitioners, and nurses may benefit from this colloquium.

Cancellation

The University reserves the right to cancel or postpone any course because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University is not responsible for any related costs, charges, or expenses. Preregistered participants will be notified if a program is filled or canceled.

Access (ADA)

Penn State encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of special accommodation or have questions about the physical access provided, please contact Continuing Education at least one week in advance of your participation or visit.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

Disclosure and Conflict of Interest (COI and educational balance)

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission, and employment without regard to personal characteristics not related to ability, performance, or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity, or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment, or retaliation against faculty, staff, or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; tel 814-863-0471/TTY. US M.Ed. J6015-17

Jump to ...